ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Multi-omics of the expression and clinical outcomes of TMPRSS2 in human various cancers: A potential therapeutic target for COVID-19

Liu, Li; Qin, Ju-Fang; Zuo, Man-Zhen; Zhou, Quan*1
Journal of Cellular and Molecular Medicine2022-2DOI: 10.1111/jcmm.17090
2被引9阅读
引用收藏
分享

摘要

Growing evidence has shown that Transmembrane Serine Protease 2 (TMPRSS2) not only contributes to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, but is also closely associated with the incidence and progression of tumours. However, the correlation of coronavirus disease (COVID-19) and cancers, and the prognostic value and molecular function of TMPRSS2 in various cancers have not been fully understood. In this study, the expression, genetic variations, correlated genes, immune infiltration and prognostic value of TMPRSS2 were analysed in many cancers using different bioinformatics platforms. The observed findings revealed that the expression of TMPRSS2 was considerably decreased in many tumour tissues. In the prognostic analysis, the expression of TMPRSS2 was considerably linked with the clinical consequences of the brain, blood, colorectal, breast, ovarian, lung and soft tissue cancer. In protein network analysis, we determined 27 proteins as protein partners of TMPRSS2, which can regulate the progression and prognosis of cancer mediated by TMPRSS2. Besides, a high level of TMPRSS2 was linked with immune cell infiltration in various cancers. Furthermore, according to the pathway analysis of differently expressed genes (DEGs) with TMPRSS2 in lung, breast, ovarian and colorectal cancer, 160 DEGs genes were found and were significantly enriched in respiratory system infection and tumour progression pathways. In conclusion, the findings of this study demonstrate that TMPRSS2 may be an effective biomarker and therapeutic target in various cancers in humans, and may also provide new directions for specific tumour patients to prevent SARS-CoV-2 infection during the COVID-19 outbreak.

学科与关键词

关键词
bioinformaticscancer progressionmulti-omics analysisprognostic analysisprognostic biomarkersTMPRSS2
相关
加载中…
  • High expression of ACE2 and TMPRSS2 and clinical characteristics of COVID-19 in colorectal cancer patients
    Liu, Chao; Wang, Kai; Zhang, Min; Hu, Xiaoyu; Hu, Tian; Liu, Yumei; Hu, Qinyong*; Wu, Shikai*; Yue, Jinbo*npj Precision Oncology, 2021, 5(1): 1.被引 29
  • Landscape Profiling Analysis of DPP4 in Malignancies: Therapeutic Implication for Tumor Patients With Coronavirus Disease 2019
    Shu, Lingling*; Liu, Yang; Li, Jinyuan; Wu, Xiaoping; Li, Yang; Huang, HanyingFrontiers in Oncology, 2021, 11: 624899.被引 12
  • Impacts of transmembrane serine protease 4 expression on susceptibility to severe acute respiratory syndrome coronavirus 2
    Tan, Qi; Fu, Jiewen; Liu, Zhiying; Deng, Haoyue; Zhang, Lianmei; He, Jiayue; Li, Xiaotao; Fu, JunjiangChinese Medical Journal, 2023, 136(7): 860-862.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Cellular and Molecular Medicine
发表日期
2022-02
卷期
第 26 卷, 第 3 期
页码
709-724
DOI
10.1111/jcmm.17090
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
Key Project of Hubei Provincial Health Commission Joint Foundation [WJ2019H500]; General Project of Hubei Natural Science Foundation [2020CFB643]

作者

  • L

    Liu, Li (第一作者)

    1 · china three gorges univ

  • Q

    Qin, Ju-Fang

    1 · china three gorges univ

查看全部 4 位作者收起作者
  • Z

    Zuo, Man-Zhen

    1 · china three gorges univ

  • Z

    Zhou, Quan (通讯)

    1 · china three gorges univ · 2

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417